NSE:STARHEALTH Stock Forecast

Stock Price Forecast

According to 23 analysts polled by S&P Global, NSE:STARHEALTH stock has a consensus rating of "Buy" and an average price target of ₹580.70. The average 1-year stock price forecast is 2.77% higher than the current stock price, while the lowest is ₹420.00 (-25.67%) and the highest is ₹700.00 (+23.88%).

Price Target: ₹580.70 (+2.77%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹420.00	₹580.70	₹600.00	₹700.00
Change	-25.67%	+2.77%	+6.19%	+23.88%

Analyst Ratings

The average analyst rating for NSE:STARHEALTH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	10	13	14	14	14	14
Buy	3	2	2	2	2	2
Hold	5	3	3	3	3	3
Sell	2	2	2	2	2	2
Strong Sell	2	2	1	1	1	1
Total	22	22	22	22	22	22

Financial Forecast

Revenue This Year

217.73B

from 178.33B

22.09%

from 178.33B

Revenue Next Year

250.11B

from 217.73B

14.87%

from 217.73B

EPS This Year

16.99

from 9.47

79.42%

from 9.47

EPS Next Year

21.73

from 16.99

27.87%

from 16.99

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	106.03B	121.00B	140.25B	161.10B	178.33B	217.73B
Revenue Growth	109.94%	14.12%	15.91%	14.87%	10.69%	22.09%
Net Income	-10.41B	6.19B	8.45B	6.46B	5.57B	9.99B
EPS	-	-	-	-	9.47	16.99
EPS Growth	-	-	-	-	-12.80%	79.42%
Forward PE	205.61	33.39	29.70	22.39	32.14	33.26
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	228.2B
Avg	217.7B
Low	208.0B

Revenue Growth

Revenue Growth	2027	2028	2029
High	28.0%
Avg	22.1%
Low	16.6%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	16.99
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	79.4%
Low	-